AYAH JAAFAR: Open Payments
NPI 1407206105 · DEARBORN, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,805 in 82 payments from 9 companies in 2025. Trend: 2023 $239 · 2024 $1,619 · 2025 $1,805
Food & beverage: $1,805
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 23 | $467 |
| Otsuka America Pharmaceutical, Inc. | 15 | $358 |
| Lundbeck LLC | 13 | $304 |
| ABBVIE INC. | 12 | $221 |
| Vanda Pharmaceuticals Inc. | 6 | $192 |
| Axsome Therapeutics, Inc. | 6 | $136 |
| Janssen Pharmaceuticals, Inc | 3 | $61 |
| Alkermes, Inc. | 3 | $51 |
| Luye Pharma (USA) Ltd. | 1 | $15 |
Products named: REXULTI, CAPLYTA, VRAYLAR, FANAPT, Auvelity, ABILIFY MAINTENA, INVEGA SUSTENNA, ARISTADA.
Industry payments across MI — which companies pay providers there.
